21 Feb, EOD - Indian

SENSEX 75311.06 (-0.56)

Nifty 50 22795.9 (-0.51)

Nifty Bank 48981.2 (-0.72)

Nifty IT 40544.5 (-0.79)

Nifty Midcap 100 50486.2 (-1.32)

Nifty Next 50 60466.8 (-0.94)

Nifty Pharma 20385.65 (-1.92)

Nifty Smallcap 100 15636.9 (-0.70)

21 Feb, EOD - Global

NIKKEI 225 38776.94 (0.26)

HANG SENG 23477.92 (3.99)

S&P 6041.75 (-1.74)

LOGIN HERE

companylogoPrivi Speciality Chemicals Ltd

You are Here : Home > Markets > CompanyInformation > Board Meeting
BSE Code : 530117 | NSE Symbol : PRIVISCL | ISIN : INE959A01019 | Industry : Chemicals |


Board Meeting
Announcement Date Date Of Meeting Purpose Detail
03-Feb-2025 12-Feb-2025 Quarterly Results Privi Speciality Chemicals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/02/2025 inter alia to consider and approve BM Intimation - to consider and approve Unaudited Financial Results for third quarter and nine months ended December 31 2024 Outcome of the Board meeting held on February 12, 2025 pursuant to regulation 30 read with regulation 33 of SEBI (LODR) Regulations 2015 (As Per BSE Announcement Dated on: 12/02/2025)
25-Nov-2024 29-Nov-2024 Employee Stock Option Privi Speciality Chemicals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/11/2024 inter alia to consider and approve Intimation of the Board Meeting to consider & approve 'Privi Employee Stock Option Scheme 2024' Outcome of the Board Meeting held on November 29, 2024 pursuant to regulation 30 of SEBI (LODR) Regulations, 2015 Outcome of the Board meeting held on November 29, 2024 pursuant to regulation 30 of SEBI (LODR) Regulations, 2015 (As Per BSE Announcement Dated on 29.11.2024)
14-Oct-2024 24-Oct-2024 Quarterly Results Privi Speciality Chemicals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 24/10/2024 inter alia to consider and approve Initimation of Board Meeting Scheduled to be held on October 24 2024 to consider amd approve Un-audited Financial Results for quarter ended Septemner 30 2024 Outcome of the Board Meeting held on October 24, 2024, pursuant to Regulation 30 read with Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 Outcome of the Board meeting held on October 24, 2024 pursuant to regulation 30 read with regulation 33 of SEBI (LODR) Regulations, 2015 (As Per BSE Announcement Dated on 24.10.2024)
20-Jul-2024 29-Jul-2024 Quarterly Results Privi Speciality Chemicals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/07/2024 inter alia to consider and approve Intimation of Board Meeting scheduled to be held on June 29 2024 inter alia to consider and approve the Unaudited Standalone & Consolidated Financial Results for the quarter ended June 30 2024. Outcome of Board Meeting held on July 29, 2024, inter alia to consider and approve Unaudited Financials (Standalone & Consolidated) for the quarter ended June 30, 2024. Outcome of Board Meeting held on July 29, 2024 (As Per BSE Announcement dated on 29.07.2024)
24-Jun-2024 24-Jun-2024 Acquisitions Outcome of the board meeting held on June 24, 2024 to consider and approve strategic investment ('Proposed Acquisition')
22-Apr-2024 02-May-2024 Preferential Issue Privi Speciality Chemicals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 02/05/2024 inter alia to consider and approve Audited Financials Results for FY 2023-24 recommendation of Final Dividend and raising fund through Qualified Institutional Placement. Outcome of the Board meeting-book closure of the AGM Outcome of the Board Meeting held on Thursday, May 02, 2024, pursuant to Regulation 30 read with Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 Outcome of Board meeting - Board approve dividend Outcome of the Board meeting-record date for dividend Outcome of the Board meeting held on Thursday, May 02, 2024 Outcome of the Board meeting- re-appointment of Chairman & Managing Director (As Per BSE Announcement Dated on 02.05.2024) Revision in record date (As per BSE Announcement Dated on 04/05/2024)
15-Jan-2024 25-Jan-2024 Quarterly Results Privi Speciality Chemicals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 25/01/2024 inter alia to consider and approve Intimation of Board Meeting scheduled to be held on January 25 2024 to consider and approve Unaudited Financial Results for the period ended December 31 2023 Outcome of the Board Meeting held on January 25, 2024 Outcome of Board Meeting held on Janauray 25, 2024 for declaration of Unaudited Financial resultd for the period ended December 31, 2023 and Reconctitution of Committees of the Board. (As per BSE Announcement Dated on 25/01/2024)
30-Oct-2023 06-Nov-2023 Quarterly Results Privi Speciality Chemicals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 06/11/2023 inter alia to consider and approve Intimation of Board Meeting Scheduled to be held on Monday= November 06 2023 Outcome of Board Meeting held on Monday, November 06, 2023 Outcome of BM held on November 06, 2023 interalia to approve Unaudited Financial Statements (Standalone & Consolidated) for quarter & year ended September 30, 2023 Outcom of Board Meeting held on November 06, 2023 interalia to appoint Additional Director (in capacity of Independent Director) (As Per BSE Announcement Dated on 06.11.2023)
25-Jul-2023 03-Aug-2023 Quarterly Results Privi Speciality Chemicals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 03/08/2023 inter alia to consider and approve Board Meeting Intimation interalia to consider and approve the Un-audited Standalone and Consolidated Financial Results (under Ind-AS) for the quarter ended on June 30 2023. Outcome of Board Meeting held on August 03, 2023, approving Unaudited Financial Results for quarter ended June 30, 2023 Outcome of Board Meeting held on Augist 03, 2023 inter alia to approve Unaudited Financial Results for quarter ended June 30, 2023. (As Per BSE Announcement dated on 03.08.2023)
18-May-2023 29-May-2023 Accounts Privi Speciality Chemicals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/05/2023 inter alia to consider and approve Intimation of Board Meeting to be held on Monday May 29 2023 inter alia to consider and approve the Audited Standalone & Consolidated Financial Results of the Company for the quarter and Financial Year ended March 31 2023 Outcome of the Board Meeting held on May 29, 2023, pursuant to Regulation 30 read with Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 A) Re-appointment of Mr. Bhaktavatsala Doppalapudi Rao (DIN: 00356218) as an Executive Director of the Company for the period of 3 years w.e.f. August 13, 2023, to August 12, 2026, subject to approval of the Members/Shareholders in the ensuing Annual Geneal Meeting. B) Re-appointment of Mr. Dwarko Topandas Khilnani (DIN: 01824655) as an Independent Director of the Company for the second consecutive term for the period of five years w.e.f. April 01, 2024. C) Approved the re-appointment of Mr. Anurag Surana (DIN: 00006665) as an Independent Director of the Company for the second consecutive term for the period of five years w.e.f. April 01, 2024. (As Per BSE Announcement dated on 29.05.2023)
17-Jan-2023 02-Feb-2023 Quarterly Results Privi Speciality Chemicals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 02/02/2023 inter alia to consider and approve Intimation of Board Meeting scheduled to be held on Thursday February 02 2023 Outcome of the Board Meeting held on February 02, 2023, pursuant to Regulation 30 read with Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 Outcome of the Board Meeting held on February 02, 2023, pursuant to Regulation 30 read with Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (As Per BSE Announcement Dated on 02.02.2023)
28-Oct-2022 07-Nov-2022 Quarterly Results Privi Speciality Chemicals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 07/11/2022 inter alia to consider and approve Intimation of Board Meeting scheduled to be held on Monday November 07 2022 Outcome of the Board Meeting held on November 07, 2022, pursuant to Regulation 30 read with Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (As Per BSE Announcement Dated on 07.11.2022)
02-Aug-2022 10-Aug-2022 Quarterly Results Privi Speciality Chemicals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/08/2022 inter alia to consider and approve Un-audited Financial Results (Standalone and Consolidated) for the quarter ended June 30 2022 Outcome of the Board Meeting held on August 10, 2022, pursuant to Regulation 30 read with Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 Outcome of Board Meeting - dated August 10, 2022 Outcome of Board Meeting - 10.08.2022 (As Per BSE Announcement dated on 10.08.2022)
28-Apr-2022 05-May-2022 Accounts Audited Results & Final Dividend Privi Speciality Chemicals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 05/05/2022 ,inter alia, to consider and approve Intimation of Board Meeting to be held on Thursday, May 05, 2022 BM Intimation for raising of Funds Privi Speciality Chemicals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 05/05/2022 ,inter alia, to consider and approve Update on Board meeting - To consider Prospective Transactions for raising funds. (As Per BSE Announcement dated on 02.05.2022) Outcome of Board Meeting held on May 05, 2022 Audited Financial Results - Standalone & Consolidated - Outcome of Board Meeting held on May 05, 2022 (As Per BSE Announcement Dated on 05/05/2022)
19-Jan-2022 27-Jan-2022 Quarterly Results Privi Speciality Chemicals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 27/01/2022 inter alia to consider and approve Un-audited Financial Results on a standalone and consolidated basis for the Third Quarter and Nine months ended on December 31 2021. Outcome of Board Meeting held on January 27, 2021 (As per BSE Announcement Dated on 27/01/2022)
1 2 

Capital Market Publishers India Pvt. Ltd

401, Swastik Chambers, Sion Trombay Road, Chembur, Mumbai - 400 071, India.

Formed in 1986, Capital Market Publishers India Pvt Ltd pioneered corporate databases and stock market magazine in India. Today Capitaline corporate database cover more than 35,000 listed and unlisted Indian companies. Latest technologies and standards are constantly being adopted to keep the database user-friendly, comprehensive and up-to-date.

Over the years the scope of the databases has enlarged to cover economy, sectors, mutual funds, commodities and news. Many innovative online and offline applications of these databases have been developed to meet various common as well as customized requirements.

While all the leading institutional investors use Capitaline databases, Capital Market magazine gives access to the databases to individual investors through Corporate Scoreboard. Besides stock market and company-related articles, the magazine’s independent and insightful coverage includes mutual funds, taxation, commodities and personal finance.

The power of the database is harnessed by our fired-up reporters to generate interesting ideas. The reader-friendly presentation of the idea, supplemented by relevant data and information, can be accessed online through Capita Telefolio and Telefolio Gold. These ideas are used by individual investors as well as institutional investors to do further research and stay ahead.

Copyright @ Capital Market Publishers India Pvt.Ltd

Designed, Developed and maintained by CMOTS Infotech (ISO 9001:2015 Certified)

Site best viewed in Internet Explorer Edge ,   Google Chrome 115.0.5790.111 + ,   Mozilla Firefox 115.0.3 + ,   Opera 30.0+, Safari 16.4.1 +